These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32059073)

  • 1. Estimating treatment effects under untestable assumptions with nonignorable missing data.
    Gomes M; Kenward MG; Grieve R; Carpenter J
    Stat Med; 2020 May; 39(11):1658-1674. PubMed ID: 32059073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copula selection models for non-Gaussian outcomes that are missing not at random.
    Gomes M; Radice R; Camarena Brenes J; Marra G
    Stat Med; 2019 Feb; 38(3):480-496. PubMed ID: 30298525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Two-Step Approach for Analysis of Nonignorable Missing Outcomes in Longitudinal Regression: an Application to Upstate KIDS Study.
    Liu D; Yeung EH; McLain AC; Xie Y; Buck Louis GM; Sundaram R
    Paediatr Perinat Epidemiol; 2017 Sep; 31(5):468-478. PubMed ID: 28767145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heckman-type selection models to obtain unbiased estimates with missing measures outcome: theoretical considerations and an application to missing birth weight data.
    Koné S; Bonfoh B; Dao D; Koné I; Fink G
    BMC Med Res Methodol; 2019 Dec; 19(1):231. PubMed ID: 31815610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A model for adjusting for nonignorable verification bias in estimation of the ROC curve and its area with likelihood-based approach.
    Liu D; Zhou XH
    Biometrics; 2010 Dec; 66(4):1119-28. PubMed ID: 20222937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjusting for nonignorable missingness when estimating generalized additive models.
    Xie H
    Biom J; 2010 Apr; 52(2):186-200. PubMed ID: 20422637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Empirical Likelihood in Nonignorable Covariate-Missing Data Problems.
    Xie Y; Zhang B
    Int J Biostat; 2017 Apr; 13(1):. PubMed ID: 28441139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Handling Protest Responses in Contingent Valuation Surveys.
    Pennington M; Gomes M; Donaldson C
    Med Decis Making; 2017 Aug; 37(6):623-634. PubMed ID: 28199176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of crossover designs for longitudinal binary data with ignorable and nonignorable dropout.
    Wang X; Chinchilli VM
    Stat Methods Med Res; 2022 Jan; 31(1):119-138. PubMed ID: 34779672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heckman imputation models for binary or continuous MNAR outcomes and MAR predictors.
    Galimard JE; Chevret S; Curis E; Resche-Rigon M
    BMC Med Res Methodol; 2018 Aug; 18(1):90. PubMed ID: 30170561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian pattern-mixture models for dropout and intermittently missing data in longitudinal data analysis.
    Blozis SA
    Behav Res Methods; 2024 Mar; 56(3):1953-1967. PubMed ID: 37221346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maximum likelihood methods for nonignorable missing responses and covariates in random effects models.
    Stubbendick AL; Ibrahim JG
    Biometrics; 2003 Dec; 59(4):1140-50. PubMed ID: 14969495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multivariate linear mixed models with censored and nonignorable missing outcomes, with application to AIDS studies.
    Lin TI; Wang WL
    Biom J; 2022 Oct; 64(7):1325-1339. PubMed ID: 35723051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifiability and estimation of causal effects in randomized trials with noncompliance and completely nonignorable missing data.
    Chen H; Geng Z; Zhou XH
    Biometrics; 2009 Sep; 65(3):675-82. PubMed ID: 18759847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A tractable method to account for high-dimensional nonignorable missing data in intensive longitudinal data.
    Yuan C; Hedeker D; Mermelstein R; Xie H
    Stat Med; 2020 Sep; 39(20):2589-2605. PubMed ID: 32367549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Flexible Bayesian Approach to Monotone Missing Data in Longitudinal Studies with Nonignorable Missingness with Application to an Acute Schizophrenia Clinical Trial.
    Linero AR; Daniels MJ
    J Am Stat Assoc; 2015 Mar; 110(509):45-55. PubMed ID: 26236060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A bivariate pseudolikelihood for incomplete longitudinal binary data with nonignorable nonmonotone missingness.
    Sinha SK; Troxel AB; Lipsitz SR; Sinha D; Fitzmaurice GM; Molenberghs G; Ibrahim JG
    Biometrics; 2011 Sep; 67(3):1119-26. PubMed ID: 21155748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of Instrumental Variable Bounds for Data Missing Not at Random.
    Marden JR; Wang L; Tchetgen EJT; Walter S; Glymour MM; Wirth KE
    Epidemiology; 2018 May; 29(3):364-368. PubMed ID: 29394191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonstandard conditionally specified models for nonignorable missing data.
    Franks AM; Airoldi EM; Rubin DB
    Proc Natl Acad Sci U S A; 2020 Aug; 117(32):19045-19053. PubMed ID: 32723822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.